Business Context and Reporting Period
This Form 8-K reports on the 2024 Annual Meeting of Stockholders held by Disc Medicine, Inc. on June 12, 2024. The filing details the voting results for director elections and the ratification of the independent registered public accounting firm.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting outcomes.
Material Changes and Voting Results
Proposal 1: Election of Class I Directors
Stockholders elected two Class I directors for a three-year term ending in 2027:
- Mona Ashiya, Ph.D.: Received 21,799,456 votes for, 149,253 votes withheld, and 885,757 broker non-votes.
- Kevin Bitterman, Ph.D.: Received 16,982,922 votes for, 4,965,787 votes withheld, and 885,757 broker non-votes.
Proposal 2: Ratification of Independent Auditor
Stockholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024. The vote results were:
- Votes For: 22,832,763
- Votes Against: 1,152
- Abstain: 551
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. No other matters were submitted to a vote at the Annual Meeting.
Investor Verification Checklist
- Verify the term length and qualifications of the newly elected directors, Mona Ashiya and Kevin Bitterman.
- Review the Definitive Proxy Statement on Schedule 14A (filed May 1, 2024) for detailed background on the director nominees and auditor ratification.
- Confirm the high level of support for the auditor ratification (over 99% of votes cast were in favor).
- Note the significant number of votes withheld for Kevin Bitterman compared to Mona Ashiya.